Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | KIVU-107 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on KIVU-107, a putative antibody-drug conjugate (ADC) targeting PTK7 (Jan 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| KIVU-107 | KIVU107|KIVU 107 | PTK7 Antibody 5 | Limited information is currently available on KIVU-107, a putative antibody-drug conjugate (ADC) targeting PTK7 (Jan 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07229313 | Phase I | KIVU-107 | A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors | Recruiting | AUS | 0 |